Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Australian 'Omni Biotech': Completed $300k pre-seed round in December 2023 to develop world-first real-time hydration monitoring using existing wearable/smartphone sensors. Validation study ongoing at Monash University. No clinical drug results as it is a digital health/device play. US 'Omni Bio Pharmaceutical': Developing new uses for plasma-derived/recombinant alpha‑1 antitrypsin with focus on immune-mediated inflammatory diseases. No recent published clinical trial results found; programs appear early-stage or preclinical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omini.